Hiv protease inhibitors

Details Hiv protease inhibitors Hiv protease inhibitors

C - Chemistry, Metallurgy

07

C

C07C 235/42 (2006.01) A61K 31/165 (2006.01) A61K 31/33 (2006.01) C07C 235/66 (2006.01) C07C 237/30 (2006.01) C07C 323/42 (2006.01) C07C 323/60 (2006.01) C07C 323/62 (2006.01) C07C 323/63 (2006.01) C07D 207/16 (2006.01) C07D 211/60 (2006.01) C07D 211/78 (2006.01) C07D 213/38 (2006.01) C07D 213/40 (2006.01) C07D 213/68 (2006.01) C07D 213/70 (2006.01) C07D 213/74 (2006.01) C07D 213/75 (2006.01) C07D 213/81 (2006.01) C07D 213/82 (2006.01) C07D 213/89 (2006.01) C07D 215/08 (2006.01) C07D 217/04 (2006.01) C07D 21

Patent

CA 2153777

HIV protease inhibitors, obtainable by chemical synthesis, block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and possibly other anti-viral agents as ingredients, are thus suitable for the treatment of the HIV virus known to cause AIDS.

Affiliated with

Also associated with

Rating

Hiv protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hiv protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hiv protease inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1600345